|
No
|
PY No |
Program Requirements
|
|
1
|
ÜPY1
|
To raise creative individuals who are able to think critically and solve problems, constantly upgrade themselves in personal and professional fields, are environmentally conscious, respect diversity, and who use their knowledge and skills for the benefit of humanity and the country
|
|
2
|
ÜPY2
|
To carry out qualified interdisciplinary research that contributes to science and art at a universal level, respecting ethical values, on the path to becoming an innovative university
|
|
3
|
ÜPY3
|
Being the first university of the Republic, with the awareness of social responsibility, it provides services that are sensitive to the problems of the country, considerate the public interest, and contribute to the development and development of the country and the city in which it lives, as an employee of the kitchen of ideas.
|
|
4
|
BPY1
|
Training experts who can access printed and electronic information sources using scientific research methods and have the ability to compile, interpret and evaluate information.
|
|
5
|
BPY2
|
Training experts who can apply their theoretical knowledge to the field of study using their critical thinking ability, follow the developments in their field, and apply relevant experimental approaches by complying with ethical principles when necessary.
|
|
6
|
PY1
|
Training individuals to prepare basic drug formulations in the laboratory.
|
|
7
|
PY2
|
Training individuals knowledgeable about the sources of drugs, doses in animals, pharmacokinetics, pharmacodynamics, and their use.
|
|
8
|
PY3
|
Training individuals knowledgeable about the licensing, distribution, sale, promotion, and pharmacovigilance of veterinary drugs.
|
|
9
|
PY4
|
Training individuals capable of utilizing theoretical and applied knowledge acquired in the field of veterinary pharmacology and toxicology.
|
|
10
|
PY5
|
Training individuals knowledgeable about the sources of poisons, prevention of poisoning in animals, and equipped with knowledge of first aid, diagnosis, and treatment.
|
|
11
|
PY6
|
|
|
12
|
PY7
|
|
|
13
|
PY8
|
|
|
14
|
PY9
|
|
|
15
|
PY10
|
|
|
16
|
PY11
|
|
|
17
|
PY12
|
|
|
18
|
PY13
|
|
|
19
|
PY14
|
|
|
20
|
PY15
|
|